COMPARISON OF MEDROXALOL AND LABETALOL, DRUGS WITH COMBINED ALPHA-ADRENOCEPTOR AND BETA-ADRENOCEPTOR ANTAGONIST PROPERTIES

被引：8

作者：

ELLIOTT, HL

MCLEAN, K

MEREDITH, PA

SUMNER, DJ

REID, JL

机构：

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1984年 / 17卷 / 05期

关键词：

D O I：

10.1111/j.1365-2125.1984.tb02391.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：565 / 572

页数：8

相关论文

共 21 条

[1] BAUM T, 1981, J PHARMACOL EXP THER, V218, P444
[2] BRITTAIN RT, 1976, BRIT J CLIN PHARMACO, V3, P681
[3] CARDIOVASCULAR PROPERTIES OF MEDROXALOL, A NEW ANTIHYPERTENSIVE DRUG
DAGE, RC
CHENG, HC
WOODWARD, JK
[J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1981, 3 (02) : 299 - 315
[4] VASODILATION BY MEDROXALOL MEDIATED BY BETA-2-ADRENERGIC RECEPTOR STIMULATION
DAGE, RC
HSIEH, CP
SPEDDING, M
[J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1983, 5 (01) : 143 - 150
[5] SIMULTANEOUS RADIOENZYMATIC DETERMINATION OF PLASMA AND TISSUE ADRENALINE, NORADRENALINE AND DOPAMINE WITHIN FEMTOMOLE RANGE
DAPRADA, M
ZURCHER, G
[J]. LIFE SCIENCES, 1976, 19 (08) : 1161 - 1174
[6] COMPARISON OF THE CLINICAL PHARMACOKINETICS AND CONCENTRATION-EFFECT RELATIONSHIPS FOR MEDROXALOL AND LABETALOL
ELLIOTT, HL
MEREDITH, PA
SUMNER, DJ
REID, JL
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 17 (05) : 573 - 578
[7] IMMEDIATE CARDIOVASCULAR-RESPONSES TO ORAL PRAZOSIN - EFFECTS OF CONCURRENT BETA-BLOCKERS
ELLIOTT, HL
MCLEAN, K
SUMNER, DJ
MEREDITH, PA
REID, JL
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (03) : 303 - 309
[8] PHARMACOLOGY OF AH 5158 - DRUG WHICH BLOCKS BOTH ALPHA-ADRENOCEPTORS AND BETA-ADRENOCEPTORS
FARMER, JB
LEVY, GP
KENNEDY, I
MARSHALL, RJ
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 1972, 45 (04) : 660 - &
[9] FRISHMAN WH, 1981, AM J CARDIOL, V48, P917, DOI 10.1016/0002-9149(81)90359-3
[10] BETA-ADRENOCEPTOR AND ALPHA-ADRENOCEPTOR ANTAGONISM BY MEDROXALOL IN HEALTHY-VOLUNTEERS - RELATIONSHIP TO DOSE AND PLASMA-CONCENTRATION
JAILLON, P
WEISSENBURGER, J
BIOUR, M
CHEYMOL, G
HAEGELE, K
SCHECHTER, PJ
KOCHWESER, J
[J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1982, 4 (05) : 705 - 713